SCHEMBL5982017

SCHEMBL5982017

CC1=CC(C)=C(Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5981117 0.78
SCHEMBL11075527 0.71
SCHEMBL20076836 0.70
SCHEMBL19113667 0.70 CA1 (0.34)
SCHEMBL565535 0.67 NOS3 (0.35)
SCHEMBL24526328 0.67
SCHEMBL12023551 0.67
SCHEMBL14260037 0.67
SCHEMBL13602041 0.65 PTPN1 (0.34)
SCHEMBL124557 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-08-31 US disclosed
EP-3463624-B1 PROCESS AND APPARATUS FOR SEPARATING GASES EVONIK SPECIALTY CHEMICALS SHANGHAI CO LTD (CN) 2021-06-23 EP disclosed
EP-3251679-B1 NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDANT GLUCOSE TRANSPORTER MITSUBISHI TANABE PHARMA CORP (JP) 2020-12-16 EP disclosed
EP-2514756-A1 Novel compounds having inhibitory activity against sodium-dependant glucose transporter Mitsubishi Tanabe Pharma Corporation (JP) 2012-10-24 EP disclosed
WO-2012061260-A1 ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-05-10 WO disclosed
WO-2012046882-A1 1,4-OXAZEPANE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-12 WO disclosed